bg image

About (full)

About 3Sixty

3Sixty Public Affairs is a government relations and public
policy consulting firm serving the health and life sciences sectors. We help create bridges between governments, businesses and civil society. 3Sixty provides clients with advocacy solutions, public affairs engagement training and workshops, and research and analysis. We are based in Ottawa, Montreal and Toronto, with strategic partnerships in the rest of the country.

Client Services

Client Services

  • Provincial, federal and national government relations strategies
  • Market access strategies
  • Negotiation support for product listing agreements at the provincial and national level
  • Public affairs campaigns and advocacy / awareness events
  • Stakeholder mapping, tracking and engagement
  • Facilitating meetings and workshops
  • Coalitions, alliances and consensus-building
  • Advocacy training
  • Speaking engagements and webinars on Canadian political dynamics and health and life sciences policy
  • Industry briefings
  • Policy position papers, white papers, briefing notes and correspondence
  • Submissions in response to government-led consultations
  • Monitoring, researching and analyzing policy issues and events
bg image

Insights (full)

Insights

 

2017

“Meet the Manager: Imran Ali – Senior Manager, pan-Canadian Pharmaceutical Alliance office”, Gerry Jeffcott, Provincial Reimbursement Advisor, February 2017

2016

“Pharmaceutical Policy Insights from a Former Provincial Minister of Health”, Gerry Jeffcott, Provincial Reimbursement Advisor, November 2016

“Canadian Orphan Drug Policies: Moving Forward, Slowly”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2016

“Companion Diagnostics for Innovative Pharmaceuticals: Facilitators or Obstacles to Market Access?”, Rachael Manion and Bill Dempster, Provincial Reimbursement Advisor, August 2016

“pCPA Delaying the Start of Negotiations: What Can Be Done?”, Johanne Chambers and Gerry Jeffcott, Provincial Reimbursement Advisor, August 2016

“PharmaFocus 2020”, Gerry Jeffcott, Rachael Manion, Alexandra Kyriakos, Bill Dempster and Michel Parent, June 2016

“Ontario Prepares for Public Drug Program Revamp”, Alexandra Kyriakos and Bill Dempster, Provincial Reimbursement Advisor, May 2016

“Competing Pressures: Market Growth Versus Provincial Budget Constraints”, Gerry Jeffcott, Provincial Reimbursement Advisor, February 2016

“A New Federal Government: Sunny Ways or Gloomy Days Ahead for the Pharmaceutical Industry?”, Bill Dempster and Johanne Chambers, Provincial Reimbursement Advisor, February 2016

2015

“Five Years of the pCPA — Impact and Opportunities for Industry”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2015

“Canada: The Impact on Drug Reimbursement of Healthcare System Reform in Quebec”, Johanne Chambers and Dima Samaha, IMS Pharma Pricing & Reimbursement, September 2015, Vol. 20(9)

“Implementation of Bill C-17 – Impact on Market Access”, Bill Dempster and Rachael Manion, Provincial Reimbursement Advisor, August 2015

“CADTH in Transition: Exploring Reforms to Align Reimbursement Reviews”, Gerry Jeffcott and Johanne Chambers, Provincial Reimbursement Advisor, August 2015

“Examining Models for a National Pharmacare Program”, Bill Dempster and Gerry Jeffcott, June 18, 2015

“PharmaFocus 2019”, Gerry Jeffcott, Bill Dempster, Alexandra Kyriakos, Rachael Manion, and Michel Parent, June 2015

“Health System Shake-Up in Quebec – Impact on Drug Reimbursement”, Johanne Chambers and Dima Samaha, Provincial Reimbursement Advisor, May 2015

“How Prescription Drugs are Approved in Canada”, Bill Dempster and Gerry Jeffcott, April 2, 2015

“How patient groups can have more say in the drug approval process”, Bill Dempster and Johanne Chambers, February 19, 2015

“Developing a Multi-Criteria Approach for Drug Reimbursement Decision Making: An Initial Step Forward”, Francois Dionne, Craig Mitton, Bill Dempster, and Larry D. Lynd, Journal of Population Therapeutics and Clinical Pharmacology, February 12, 2015, Vol 22(1)

“The IBM Report on the pCPA”, Gerry Jeffcott and Rachael Manion, February 5, 2015

“Therapeutic Reviews: Experience in Canada and Impact on Reimbursement”, Johanne Chambers & William Dempster, IMS Pharma Pricing & Reimbursement, September, 2015, Vol. 19(6)

2014

“Evolution of Drug Reimbursement in Canada: The Pan-Canadian Pharmaceutical Alliance for New Drugs”, Don Husereau, William Dempster, Adrienne Blanchard and Johanne Chambers, Value in Health, December 2014, Vol. 17(8)

“CADTH’s New User Fee Policy: How Will it Impact Industry?”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, November 2014

“PharmaFocus 2018”, Gerry Jeffcott, Bill Dempster, Johanne Chambers, and Rachael Manion, June 2014

“Queuing at the Common Drug Review: Why the Long Waits, and What Can Be Done to Eliminate Them?”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, May 2014

“Therapeutic Reviews: Experience in Canada and Impact on Reimbursement”, Johanne Chambers and Bill Dempster, Provincial Reimbursement Advisor, February 2014

2013
2012

“Provincial and Federal Elections Aftermath: Impact on the Canadian Reimbursement Landscape”, Bill Dempster and Blake Johnston, Provincial Reimbursement Advisor, February 2012

“The Drug Shortages Challenge: Responses from Governments and Industry”, Bill Dempster, Provincial Reimbursement Advisor, August 2012

2011

“Provincial Purchasing Alliances – Drivers, Challenges and Implications”, Bill Dempster, Provincial Reimbursement Advisor, February 2011